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Abstract
Osajin is a prenylated isoflavone showing antitumor activity in different tumor cell lines. The underlying mechanism of
osajin-induced cancer cell death is not clearly understood. In the present study, the mechanisms of osajin-induced cell
death of human nasopharyngeal carcinoma (NPC) cells were explored. Osajin was found to significantly induce apoptosis of
NPC cells in a dose- and time-dependent manner. Multiple molecular effects were observed during osajin treatment
including a significant loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol, enhanced
expression of Fas ligand (FasL), suppression of glucose-regulated protein 78 kDa (GRP78), and activation of caspases-9, -8, -4
and -3. In addition, up-regulation of proapoptotic Bax protein and down-regulation of antiapoptotic Bcl-2 protein were also
observed. Taken together, osajin induces apoptosis in human NPC cells through multiple apoptotic pathways, including the
extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. Thus,
osajin could be developed as a new effective and chemopreventive compound for human NPC.
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Introduction
The flavonoids are a heterogeneous group of phenolic
compounds showing diverse biological effects such as antioxidant,
antiviral, anticancer, anti-inflammatory, and antiallergic activities
[1,2]. Flavonoids are frequently used in oncology to reduce the
side effects of cytostatics and enhance the therapeutic effects [3,4].
Osajin is a flavonoid compound isolated from the fruit of
Maclura pomifera, a tree belonging to the Moraceae or mulberry
family, and is commonly referred to as ‘‘osajin orange, hedge
apple, bow wood, and horse apple’’ [5,6]. Through suppression of
oxidative stress, osajin is cardioprotective by attenuating the
myocardial dysfunction provoked by ischemia-reperfusion in rat
hearts [7]. In addition, osajin exhibits growth inhibitory activity on
six human cancer cell lines, including kidney, lung, prostate,
breast, melanoma and colon cancer cells [8]. In contrast, the low
toxicity of osajin against hepatocytes was also reported [8]. Despite
the increasing therapeutic interest in osajin, the mechanisms of
action of osajin on nasopharyngeal carcinoma (NPC) cells remain
unaddressed.
NPC is the most common type of head-and-neck cancer
worldwide, with a distinct racial and geographic distribution across
the world [9]. It is endemic in Southeast Asia, Southern parts of
China, the Mediterranean basin, and the Middle East [10].
Etiologic factors identified for NPC include genetic susceptibility,
Epstein-Barr virus (EBV) infection, environmental factors (includ-
ing chemical carcinogens) and dietary factors [11]. NPC shows
relatively high sensitivity to radiation, and radiotherapy remains
the mainstay treatment for early stages of NPC. Moreover, some
pathological types (types 2 and 3) are chemosensitive at all stages of
the disease [12,13]. The concurrent combination of radiotherapy
and chemotherapy has improved the outcome for patients with
advanced stages of NPC. However, side effects such as fatal
toxicity and the poor outcome of recurrent disease with
chemotherapy were observed in many patients, indicating that
the development of more effective and less toxic alternatives is
urgently needed.
Dysregulation of apoptosis or programmed cell death is
emerging as a key factor for cancer development [14]. Accumu-
lating evidence clearly indicates that apoptosis is a crucial
mechanism used by dietary bioactive agents for chemoprevention
of cancers [15]. Apoptosis is characterized by morphologic and
biochemical changes including cell shrinkage, chromatin conden-
sation, and DNA fragmentation [16]. At the molecular level,
apoptosis is tightly regulated by the activation of the aspartate-
specific cysteine proteases known as caspases [17], and both
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extrinsic and intrinsic pathways have been described. The
extrinsic, death receptor-mediated pathway is activated at the cell
surface when a specific ligand binds to its corresponding cell-
surface death receptor. Stimulation of death receptors of the tumor
necrosis factor (TNF) receptor superfamily such as Fas (APO-1/
CD95) results in receptor aggregation and recruitment of the
adaptor molecule, Fas-associated death domain (FADD). Upon
recruitment, caspase-8 becomes activated and initiates apoptosis
by direct cleavage of downstream effector caspases, most notably
caspase-3 [18]. Activation of caspase-8 can also result in cleavage
of Bid, a Bcl-2 family protein with a BH3 domain only, which in
turn translocates to the mitochondria to release cytochrome c,
thereby initiating a mitochondrial amplification loop [19]. In the
mitochondria-mediated pathway, activation of mitochondria is
accompanied by the release of cytochrome c from mitochondria,
which amplify apoptosis in both the extrinsic and intrinsic
pathways. The cytochrome c then interacts with apoptosis
protease-activating factor-1 (Apaf-1), ATP and procaspase-9 to
form a supramolecular complex called the apoptosome. The
apoptosome, in turn, activates caspase-9 through autocatalysis,
and the latter then activates caspase-3, resulting in apoptosis [20].
Furthermore, the mitochondria-dependent apoptotic pathway is
tightly regulated by Bcl-2 family proteins such as Bax and Bak.
Both are proapoptotic members activated by a variety of apoptotic
stimuli, leading to oligomerization and insertion into the
mitochondrial outer membrane to release cytochrome c [21].
The intrinsic pathway is initiated within the cell when intracellular
stress acts via BH3-only proteins such as Bid and leads to
activation of Bax and Bak. This results in apoptosis independently
of the surface-bound receptors such as Fas.
Recent studies have revealed that a third subcellular compart-
ment, the endoplasmic reticulum (ER), is implicated in apoptosis
induced by ER stress [22,23]. ER stress activates the unfolded
protein response (UPR) and the ER-resident cysteine protease,
caspase-12, leading to caspase-3 activation and apoptosis [24].
However, although murine caspase-12 is an active enzyme, the
human homolog, caspase-12, contains several mutations that
render it non-functional [25]. In contrast, human caspase-4,
which is also a resident of the ER is the counterpart of murine
caspase-12 and is activated by ER stress [26]. Induction of
glucose-regulated protein GRP78, also referred to as BiP
(immunoglobulin heavy-chain binding protein), has been widely
used as a marker for ER stress and the onset of UPR. Due to its
antiapoptotic properties, stress induction of GRP78 represents an
important prosurvival component of the evolutionarily-conserved
UPR. Recent evidence shows that the microenvironment of
tumors can stimulate physiological ER stress, and GRP78 is up-
regulated in many types of cancer cells lines and tumor biopsies
[27]. The ER stress-induced apoptosis modulator also includes
CCAAT/enhancer-binding protein (C/EBP)-homologous protein
(CHOP)/growth arrest and DNA-damage-inducible gene 153
(GADD153). Overexpression of CHOP plays a central role in
apoptosis [28], including the dephosphorylation of the proapop-
totic BH3-only protein Bad [29] and down-regulation of Bcl-2
expression [30].
In the present study, the ability of osajin to kill NPC cell lines
was characterized. Osajin was found to reduce cell viability of
NPC cells through apoptosis. The underlying mechanism was
found to be due to activation of capases-9, -8, -4 and -3.
Disruption of the mitochondrial membrane potential, release of
cytochrome c from mitochondria, up-regulation of FasL and Bax,
and down-regulation of GRP78 and Bcl-2 were also observed.
Due to its broad apoptotic effects on NPC cells, osajin should be
further explored for its therapeutic potential against NPC.
Results
Osajin reduces the viability of human NPC cells
The effects of osajin on the viability of human NPC cells were
first studied. Three different types of NPC cell lines were treated
with increasing concentrations of osajin for 24 h, and were
followed by the MTT assay. As shown in Figure 1A, B and C,
osajin significantly decreased the viability of TW076, CG1 and
TW04 cells in a dose-dependent manner. In addition, a time-
dependent inhibition of the viability of TW04 cells was also
observed (Figure 1D). However, osajin at a concentration of
10 mM did not show significant effect on the viability of the human
bronchial epithelial cell line BEAS-2B (data not shown). Thus,
osajin treatment reduced the cell viability of different histological
types of NPC cell lines.
Osajin induces apoptosis and DNA fragmentation in
TW04 cells
As type 3 NPC comprises over 95% of NPC in high-incidence
areas [9], the undifferentiated carcinoma cell line TW04 (type 3
NPC) was used for subsequent mechanistic studies. To determine
whether the cytotoxic effect of osajin was mediated via apoptosis,
annexin V-FITC/PI double staining was performed. As shown in
Figure 2A and B, the percentage of apoptotic TW04 cells
increased from 6.6% in control cells to 17% and 36% after
treatment with 5 and 7.5 mM osajin, respectively.
A prominent feature of apoptosis is the degradation of
chromatin DNA at internucleosomal linkages. The ability of
osajin to induce DNA fragmentation in NPC cells was therefore
addressed. For this purpose, TW04 cells were treated with 5 and
7.5 mM osajin for 24 h and DNA was fractionated by agarose gel
electrophoresis. A typical ladder pattern of internucleosomal
fragmentation was observed in cells treated with osajin. The
ladder pattern was absent in untreated cells (Figure 2C). A Cell
Death Detection ELISA kit that specifically detects cytoplasmic
histone-associated DNA fragments was also used. Compared with
untreated control cells, osajin treatment of TW04 cells resulted in
significant dose-dependent apoptosis, with a 10 to 13-fold increase
in internucleosomal DNA fragmentation by treatment with 5 and
10 mM osajin, respectively (Figure 2D).
Osajin induces caspase-mediated apoptosis in TW04 cells
Apoptosis is executed by a family of cysteine-dependent
aspartate-specific proteases known as caspases. As caspase-3 is a
key protease associated with DNA fragmentation, we investigated
the activity of caspase-3 in osajin-treated TW04 cells by the
colorimetric assay. The enzyme activity of caspase-3 stimulated by
osajin was measured using a specific substrate, DEVD-pNA.
Caspase-3 activity was markedly increased by osajin treatment. A
1.07, 2.88 and 3.38-fold increase in DEVD-pNA cleavage was
observed after incubation with 2.5, 5 and 7.5 mM osajin for 24 h,
respectively, compared with untreated controls (Figure 3A).
To further elucidate whether activation of caspase-3 by osajin
involves extrinsic (death receptor), intrinsic (mitochondrial) or ER
stress-mediated apoptotic pathways, the activities of caspase-9, -8
and -4 , which are the apical proteases in the intrinsic, extrinsic,
and ER-mediated pathway, respectively, were also analyzed by the
colorimetric assay in TW04 cells. As shown in Figure 3A, osajin
increased the activity of capase-8 and -9 in a dose-dependent
manner compared with untreated cells. A 1.1 to 1.62-fold increase
for caspase-8 activity and 1.06 to 1.51-fold increase for caspase-9
activity were observed after incubation with 2.5–7.5 mM osajin for
24 h. By contrast, while caspase-4 activity remained unaffected by
2.5 and 5 mM osajin treatments, the activity was significantly
Osajin Induces Apoptosis of NPC Cells
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increased up to 1.51-fold by 7.5 mM osajin compared with
untreated cells. Further treatment of TW04 cells with 10 mM
caspase-3, -8 or -9 inhibitors before 5 mM osajin challenge resulted
in significant increase of cell viability (Figure 3B). However,
treatment with 10 mM caspase-4 inhibitor caused a smaller
increase in cell viability of osajin-treated TW04 cells (Figure 3B).
To further confirm the role of caspase-3, -4, -8 and -9 in osajin-
induced apoptosis, we performed gene knockdown studies using
caspase-3, -4, -8 and -9 specific siRNAs. GAPDH and non-
targeting siRNAs were used as controls. Western blot analysis
showed that the amount of caspase-3, -4, -8, -9 and GAPDH was
decreased by specific siRNAs (Figure 3C), and no effect was
observed when cells were treated with the non-targeting siRNA
control. The effect of the caspase-3, -4, -8, -9 or non-targeting
knockdown control on viability of osajin-treated TW04 cells was
also assessed (Figure 3D). Cell viability of 5 mM osajin-treated
TW04 cells was increased by transfection with caspase-3, -4, -8 or
-9 siRNA, respectively, compared with cells transfected with non-
targeting siRNA control. Altogether, osajin-induced apoptosis in
TW04 cells takes place mainly through the activation of caspase-3,
-8 and -9, and is partly associated with the activation of caspase-4.
Osajin induces loss of mitochondrial membrane potential
and release of cytochrome c into the cytosol of TW04
cells
Activation of caspase-9 is mostly due to disruption of mitochon-
drial transmembrane potential and the release of cytochrome c. The
osajin effect on mitochondrial membrane potential was studied by
flow cytometry after staining with MitoCaptureTM, a cationic dye.
Exposure of TW04 cells to osajin for 24 h caused a loss of red
fluorescence (Figure 4A,B), indicating the disruption of mitochon-
drial transmembrane potential, which was comparable to the
mitochondrial depolarization due to treatment with 5 mM camp-
tothecin as the positive control.
The release of cytochrome c was next examined by Western blot
analysis. Cytochrome c was hardly detectable in the cytosol of
untreated NPC cells, but was increased following treatment with
5 mM and 7.5 mM osajin for 24 h, respectively (Figure 4C). Thus,
osajin induced both loss of mitochondrial membrane potential and
release of cytochrome c into the cytosol.
Osajin induces FasL/CD95L expression in TW04 cells
Activation of the initiator caspase, caspase-8, often results from
stimulation of death receptors of the TNF receptor superfamily
such as Fas/CD95 or TRAIL receptor [31]. To determine
whether osajin affects levels of Fas and FasL in TW04 cells, the
mRNA and protein levels of Fas and FasL in untreated cells and
cells treated with 5 mM or 7.5 mM of osajin were evaluated. As
shown in Figure 5, the expression level of FasL increased after
exposure to osajin for 24 h, whereas Fas expression remains
unchanged. To confirm that the Fas/FasL pathway involves
osajin-induced apoptosis, we used the blocking anti-Fas mAb and
determined whether it affected osajin-induced apoptosis. Figure 6
shows that osajin-induced apoptosis in TW04 cells was signifi-
Figure 1. Effect of osajin on the viability of human NPC cells. (A) TW076 cells, (B) CG1 cells, and (C) TW04 cells were treated with various
concentrations (0.01–10 mM) of osajin for 24 h. (D) TW04 cells were treated with 5 mM osajin for the indicated times. Cell viability was determined
using the MTT assay. The data are presented as the means 6 SE of three individual experiments (*P,0.05 versus 0 mM control).
doi:10.1371/journal.pone.0018308.g001
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cantly attenuated by preincubation with anti-Fas mAb. This result
suggests that osajin induces increased FasL expression in which
contributes to apoptosis of NPC cells.
Osajin modulates the level of Bcl-2 family proteins in
TW04 cells
The release of cytochrome c is tightly regulated by members of
the Bcl-2 family known to play an important role in regulation of
apoptosis [32]. To examine whether expression of Bcl-2 or Bax
may be modulated by osajin, TW04 cells were treated with 5 mM
or 7.5 mM of osajin for 24 h, and mRNA and protein levels for
Bcl-2 and Bax were examined. As shown in Figure 5A and B,
osajin treatment significantly decreased the level of Bcl-2 mRNA,
and caused a smaller but significant decrease in Bcl-2 protein.
Concomitantly, the level of Bax proteins increased slightly, thereby
causing a significant increase in the Bax/Bcl-2 ratio that favors
apoptosis (Figure 5D). To further determine whether osajin
inhibits the function of Bcl-2 by blocking heterodimerization of
Bcl-2 and Bax, co-immunoprecipitation with Bcl-2 and Bax was
performed. Direct interaction between Bcl-2 and Bax was not
detected in either untreated or osajin-treated TW04 cells (Figure 7).
In addition, the amount of full-length Bid was reduced by 20–30%
in the cytosolic fraction of 5 and 7.5 mM osajin-treated NPC cells
(Figure 4C).
Differential regulation of GRP78/BiP and CHOP/GADD153
in osajin-treated TW04 cells
Under conditions associated with ER stress, GRP78/BiP is
recruited to misfolded proteins to facilitate their proper folding,
thus serving as a major player in the survival program [33]. On the
other hand, CHOP/GADD153 is one of several molecules
mediating ER stress-induced apoptosis [28]. Thus, the effect of
osajin on mRNA expression and protein production levels of
GRP78 and CHOP was analyzed in TW04 cells. Treatment with
osajin in TW04 cells dramatically down-regulated the levels of
GRP78 in a dose-dependent manner. In contrast, the level of
CHOP was unchanged in cells treated with different concentra-
tions of osajin (Figure 5E).
Figure 2. Osajin treatment induces apoptosis and DNA fragmentation in TW04 cells. Cells were treated with 0, 5 or 7.5 mM osajin for 24 h
and stained with Annexin V-FITC and PI. (A) Cells in the upper-right (UR) portion represent cells undergoing late apoptosis, whereas cells in the lower-
left (LL) and lower-right (LR) portions are viable and early-apoptotic cells, respectively. (B) The data indicate the percentage of annexin V-positive cells
(apoptosis). (C) Agarose gel electrophoresis of DNA fragments from cells treated with various concentrations of osajin for 24 h. M: 1 kb DNA ladder
size marker. (D) Cells were treated with various concentrations of osajin for 24 h in a 96-well plate, and the enrichment of nucleosomes in the
cytoplasm was determined using the Cell Death Detection ELISAPLUS kit. Results are shown as the means 6 SE of four independent experiments
(*P,0.05 versus 0 mM control).
doi:10.1371/journal.pone.0018308.g002
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Discussion
Chemoprevention by the use of naturally-occurring dietary
substances is attracting mounting attention as a practical approach
to reduce the ever-increasing incidence of cancers [34]. Currently
some promising dietary chemopreventive compounds include
(-)-epigallocatechin gallate (EGCG), resveratrol, lupeol, delphini-
din, curcumin, genistein, isothiocyanates, lycopene and other
substances which have in common their ability to induce apoptosis
of cancer cells [35]. Although previous studies have suggested that
osajin could be used in cancer prevention [8], the effects of osajin
on human NPC cells have not been previously characterized.
Results from this study show that osajin is cytotoxic for three
different types of NPC cell lines. Using the type 3 NPC TW04 cell
line as the study model, the mechanism of cytotoxicity was found
to depend on induction of apoptosis. Our results are thus
consistent with previous studies.
Results from this study indicate that caspase-3, -4, -8 and -9 are
all involved in osajin-induced apoptosis of TW04 cells. Although
there seems to be no dominant pathway revealed by the use of
caspase inhibitors and gene knockdown assays, a significant
increase of caspase-3 activity is due to synergistic effects of
caspase-4, -8 and -9. Furthermore, as none of the caspase
inhibitors or siRNAs rescued the NPC cells completely, our results
suggested that the caspases induced apoptosis through nonredun-
dant pathways. However, we can not exclude the possibility that
other mechanisms may regulate cell survival and apoptosis in
osajin-treated NPC cells. NPC cell treatment with osajin results in
the disruption of mitochondrial transmembrane potential, release
of cytochrome c from mitochondria, and activation of caspases-9
and -3.
The apoptotic pathway is also regulated by members of the Bcl-
2 family of proteins. This family includes a number of proteins
with homologous amino acid sequences, including antiapoptotic
Figure 3. Osajin induces caspase-dependent apoptosis in TW04 cells. (A) Cells were treated with various concentrations of osajin for 24 h.
The cytosolic fraction of the cells was then analyzed for the activities of caspases-3, -4, -8 and -9 using caspase colorimetric assay kits (*P,0.05 versus
0 mM control). (B) Cells were treated with 5 mM osajin for 24 h in the presence of caspase-3, -4, -8 or -9 inhibitors, and then cell viability was
determined by the MTT assay. The data shown are the means 6 SE of three individual experiments (*P,0.05 versus control cells treated with osajin
alone). (C) Cells were transfected with caspase-3, -4, -8, -9, GAPD control or non-targeting control siRNA (25 nM) for 48 h, and protein extracts were
prepared for Western blot using caspase-3, -4, -8, -9 and GAPDH antibodies. (D) Cells were transfected with the indicated siRNA, and cell viability after
5 mM osajin treatment for 24 h was estimated by the MTT assay. Results were expressed as the means 6 SE of three individual experiments (*P,0.05
versus non-targeting control siRNA-transfected cells).
doi:10.1371/journal.pone.0018308.g003
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members such as Bcl-2 and Bcl-xL, as well as proapoptotic
members including Bax and Bak [36,37]. Overexpression of Bax
promotes cell death [38]. Conversely, overexpression of Bcl-2
stimulates formation of a Bcl-2-Bax heterodimer, thereby
neutralizing the proapoptotic activity of Bax [39]. Results from
this study show that osajin-induced apoptosis in human NPC cells
is accompanied by down-regulation of Bcl-2 and up-regulation of
Bax. Although Bcl-2 has been reported to bind to Bax, no
interaction was detectable in untreated and osajin-treated TW04
cells. The undetectable Bcl-2/Bax interaction is not surprising,
because the Bcl-2 protein can bind to a variety of non-Bcl-2 family
proteins, such as p53, Raf-1 and Ras [40]. Previous studies also
showed that antiapoptotic Bcl-2 proteins interact with Bax weakly
[41]. Moreover, the protein level of Bcl-2 is much lower than that
of Bax in TW04 cells which could explain why the Bcl-2/Bax
interaction was not detected in TW04 cells. However, down-
regulation of Bcl-2 and up-regulation of Bax may contribute to the
alteration of the permeability of mitochondria, release of
cytochrome c into the cytosol, activation of caspase-3, and
ultimately cell death.
The Fas pathway is involved in osajin-induced apoptosis of
NPC cells. Treatment with osajin triggered the increased
expression of FasL which can stimulate the Fas receptor in an
autocrine or paracrine manner. Besides the membrane-bound
form, soluble FasL (sFasL) may also be obtained by cleavage of
membrane-bound FasL (mFasL) through a metalloprotease-like
enzyme [42]. Both mFasL and sFasL bind to Fas and subsequently
trigger apoptosis through the Fas/FasL system, but sFasL has been
reported to be a weaker inducer of apoptosis than mFasL [43].
Osajin activates expression of mFasL, which usually leads to
activation of caspase-8. As we did not measure the effect of osajin
on the amount of sFasL produced, we can not rule out the
possibility that osajin may also affect the amount of sFasL.
Interestingly, osajin did not affect expression of Fas, suggesting
that expression of Fas and mFasL may be under different
regulatory pathways. Furthermore, caspase-8 is most likely
Figure 4. Osajin causes disruption of mitochondrial membrane potential and release of cytochrome c into the cytosol. (A) TW04 cells
were treated with 7.5 mM osajin for 24 h before staining with MitoCaptureTM, a cationic dye. The mitochondrial membrane potential was measured
by flow cytometry. The shift-down of fluorescence from red to green indicates the collapse of mitochondrial membrane potential. Camptothecin was
used as a positive control for the disruption of mitochondrial membrane potential. The percentage of cells with disrupted mitochondrial membrane
potential is indicated. (B) The data indicate the percentage of cells with disruption of mitochondrial membrane potential. Results are shown as means
6 SE of four independent experiments (*P,0.05 versus 0 mM control). (C) Proteins prepared from cells treated with 5 mM or 7.5 mM osajin for 24 h
were subjected to Western blot for measurement of Bid and cytochrome c in the cytosol. b-actin was used as internal control to ensure that equal
amounts of proteins were loaded in each lane.
doi:10.1371/journal.pone.0018308.g004
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activated by the increased expression of FasL, rather than through
enhanced sensitivity of the Fas pathway in osajin-treated cells.
The activation of the death receptor pathway by osajin also
connects to the mitochondrial pathway, which involves cleavage
of the Bcl-2 family member Bid by caspase-8. Our data show a
20–30% decrease of expression of the full-length Bid protein in
the cytosolic fraction of NPC-TW04 cells after treatment with
osajin. However, no cleaved Bid was detected by Western blot
analysis after three independent experiments. Previous studies
have shown that tBid is rapidly degraded by the ubiquitin
proteolytic system, and inhibition of the proteasome therefore
increases apoptosis by increasing tBid levels [44]. It may be
possible that tBid is already degraded after osajin treatment under
our experimental conditions.
ER stress is also involved in apoptosis triggered by osajin
treatment. ER stress leads to proteolytic cleavage of caspase-12 in
the mouse and caspase-4 in humans, but both caspases localize to
the cytoplasmic side of the ER membrane [26]. Furthermore, Kim
et al. found that neuronal apoptosis in infantile neuronal ceroid
lipofuscinosis is caused by ER stress-mediated caspase-4 activation,
leading to subsequent caspase-3 activation and apoptosis [45]. Our
results showed that osajin activates caspase-4 and caspase-3.
Another protein, CHOP, known as GADD153 and a transcription
factor that decreases the expression of Bcl-2, can also induce
apoptosis [30]. CHOP/GADD153 is present at low levels under
normal conditions, but is robustly expressed in response to ER
stress [46]. Besides CHOP, the ER chaperone GRP78/BiP, which
shows antiapoptotic properties and whose expression is widely
reported in human cancer, is a central regulator of ER
homeostasis [25]. Using a genetic model of breast cancer in
GRP78–deficient mice, GRP78 heterozygous mice have no effect
on organ development or antibody production but show
significant inhibition of in situ-generated tumor growth and tumor
angiogenesis [47]. Recent studies have also revealed that GRP78
can directly inhibit ER stress-induced apoptosis through direct
binding and subsequent inhibition of caspase-7 activation [48]. In
this study, treatment of osajin down-regulated GRP78 expression
in NPC cells. However, the level of CHOP protein was constant in
osajin-treated NPC cells. Thus, osajin may modulate ER stress-
mediated apoptosis of NPC cells through regulation of GRP78.
In conclusion, although we have not identified yet a causal link
between the different apoptotic pathways and the target molecules
Figure 5. Effect of osajin on the expression of Fas/CD95, FasL/CD95L, GRP78/BiP, CHOP/GADD153 and Bcl-2 family proteins. TW04
cells were treated with various concentrations of osajin for 24 h. (A) RNA was isolated from cells treated with 5 mM or 7.5 mM osajin. Two mg of RNA
was reversely transcribed into cDNA using oligo (dT) primers. RT-PCR analysis was performed using primers specific for Fas, FasL, GRP78, CHOP, Bax
and Bcl-2 genes and also the internal control gene, b-actin. (B) Cell lysates were prepared for SDS-PAGE followed by Western blot for Fas, FasL, GRP78,
CHOP, Bax and Bcl-2, with b-actin as a loading control. (C) to (E) Results are presented as the relative densities of protein bands normalized to b-actin.
The data shown are the means 6 SE of three individual experiments (*P,0.05 versus 0 mM control).
doi:10.1371/journal.pone.0018308.g005
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of osajin remain unknown, our results indicate that osajin triggers
apoptosis of human NPC cells through multiple apoptotic
pathways (Figure 8). This is achieved by activating different
caspases via three pathways: surface death receptors, mitochon-
dria, and ER stress. These findings suggest that osajin should be
considered as a potential broad-range chemopreventive agent for
NPC.
Materials and Methods
Reagents
Osajin was purchased from Bode United Technology (Beijing,
China). Dimethyl sulfoxide (DMSO), bovine serum albumin (BSA)
and protease inhibitor cocktail were obtained from Sigma (St
Louis, MO, USA). Z-DEVD-FMK (caspase-3 inhibitor), Z-
LEVD-FMK (caspase-4 inhibitor), Z-IETD-FMK (caspase-8
inhibitor), and Z-LEHD-FMK (caspase-9 inhibitor) were pur-
chased from BioVision (Mountain View, CA, USA). Osajin was
dissolved in DMSO to make a stock solution of 50 mM stored at
220uC and diluted to the desired concentration before use. Cell
culture medium (DMEM, F-12), fetal bovine serum (FBS),
penicillin, streptomycin, and trypsin-EDTA were purchased from
Gibco BRL (Grand Island, NY, USA).
Cell lines and cell culture
Three different types of human NPC cell lines were studied:
TW076 (type 1 NPC, squamous cell carcinoma, EBV negative)
[49], CG1 (type 2 NPC, non-keratinizing carcinoma, EBV
positive) [50], and TW04 (type 3 NPC, undifferentiated
carcinoma, EBV negative) [51]. TW04 and TW076 cells were
cultured in DMEM, and CG-1 cells were cultured in DMEM/F-
12 (3:1, v/v) supplemented with 10% (v/v) FBS, 100 units/ml
penicillin and 100 mg/ml streptomycin at 37uC in a 5% CO2
incubator with saturated humidity.
Cell viability assay
Cell viability was determined using the MTT-based in vitro
toxicology assay kit (Sigma), which measures colorimetrically a
purple formazan compound produced by viable cells. Briefly, NPC
cells were seeded in 96-well plates (56103/well) and allowed to
adhere for 24 h. The medium was then substituted by a fresh one
containing different concentrations (0.01–10 mM) of osajin for
another 24 h. For the time-course assay, the incubation times with
5 mM of osajin were 6, 12, 24, 36 and 48 h. After incubation,
10 ml of 5 mg/ml of MTT was added to each well and incubated
for 4 h at 37uC. Elution of the precipitate was performed with
100 ml of solubilization solution. Cell viability was calculated from
absorption values obtained at 570 nm using an automated ELISA
reader (Cape Code, UK). All experimental concentrations were
performed in triplicate.
Annexin V-PI binding assay
To measure apoptotic cell death, an Annexin V-FITC
Apoptosis Detection Kit (BioVision) together with flow cytometry
was used according to the manufacturer’s protocol in order to
quantify the externalization of phosphatidylserine by flow
cytometry. In brief, 56105 cells grown to 60% confluence were
treated with 0, 5 and 7.5 mM of osajin for 24 h. For the Annexin
V/PI binding assay, both floating and adherent cells were
collected and washed with serum-containing media. Collected
cells were washed with serum-containing media before being
resuspended in 500 ml of 16 binding buffer, followed by addition
of 5 ml of Annexin V-FITC and 5 ml of PI to the cell suspension.
The mixture was then incubated for 5 min at room temperature in
the dark and immediately analyzed with the flow cytometer
(Becton Dickinson, San Jose, CA, USA) and Cell Quest 3.3
software (Becton Dickinson).
Figure 6. DNA fragmentation assay shows inhibition of
apoptosis in osajin-treated NPC cells by the anti-Fas mAb
ZB4. TW04 cells were preincubated for 2 h with 500 ng/ml ZB4 mAb,
and osajin (5 mM) was then added and incubation was continued for
24 h prior to cell harvesting and agarose gel electrophoresis of
fragmented DNA.
doi:10.1371/journal.pone.0018308.g006
Figure 7. Co-immunoprecipitation of Bax and Bcl-2 in osajin-
treated NPC cells. Immunoprecipitation assays were preformed as
described in Materials and Methods. TW04 cell lysates served as a
positive control; while immunoprecipitation wash buffer served as a
negative control. Cell lysates of untreated and osajin-treated TW04 cells
were immunoprecipitated by primary anti-Bax or anti-Bcl-2 antibodies.
Western blots were preformed to demonstrate whether osajin
treatment affected the heterodimerization of Bax and Bcl-2.
doi:10.1371/journal.pone.0018308.g007
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Detection of DNA fragmentation
Agarose gel electrophoresis of fragmented DNA was preformed
as previously described [52]. DNA was prepared from untreated
and osajin-treated cells by standard digestion and organic
extraction. Extracted DNA was separated by electrophoresis in
1.2% agarose gel and visualized with ethidium bromide staining.
For blocking experiments [53], TW04 cells were preincubated
with blocking 500 ng/ml anti-Fas mAb ZB4 (Millipore, Billerica,
MA, USA) for 2 h, and osajin (5 mM) was subsequently added and
incubation continued for 24 h prior to harvesting of cells. In some
experiments, apoptosis was also evaluated by assessing the
enrichment of nucleosomes in the cytoplasm, compared with
control cells. Cytoplasmic DNA fragments were quantified with a
cell death detection ELISAPLUS kit (Roche, Mannheim, Ger-
many). Briefly, cells were plated in triplicate in a 96-well plate at a
density of 16104 cells per well and were treated with osajin at
varying concentrations (1–10 mM) for 24 h. The level of apoptosis
was expressed as the enrichment factor = absorbance of the
sample/absorbance of the corresponding control.
Caspase activity assay
The activity of caspase-3, -4, -8 and -9 was measured using a
colorimetric assay kit (BioVision) according to the manufacturer’s
instructions. Cells were incubated for 24 h with different
concentrations of osajin. The cell lysate from 1–56106 cells was
incubated at 37uC for 2 h with 200 mM DEVD-p-nitroanilide
(pNA) (caspase-3 substrate), LEVD-pNA (caspase-4 substrate),
IETD-pNA (caspase-8 substrate), or LEHD-pNA (caspase-9
substrate). Spectrophotometric detection of the chromophore
pNA after cleavage from the labeled caspase substrates was then
performed. Samples were read at 405 nm and the enzyme activity
was expressed as fold-increase over untreated control samples.
Transfection of small interfering RNA (siRNA)
TW04 cells were seeded in antibiotic-free media for 24 h prior
to transfection with siRNA targeting caspase-3, caspase-4, caspase-
8, caspase-9 (ON-TARGETplus SMARTpool), corresponding
ON-TARGETplus GAPD control pool and non-targeting control
pool, which were purchased from Dharmacon (Thermo Fisher
Scientific, Lafayette, CO, USA). Cells were transfected with
25 nM siRNA in antibiotic-free complete media using Dharma-
FECT I Reagent (Dharmacon) according to the manufacturer’s
protocol. Forty-eight hours post-transfection, cells were harvested
and assayed for protein expression levels of the target of interest.
Mitochondrial membrane potential detection assay
The MitoCaptureTM Mitochondrial Apoptosis Detection kit
(BioVision) for detection of mitochondrial transmembrane transi-
tion events in live cells was used. Growing cells (60% confluence)
were treated with 7.5 mM of osajin for 24 h. Collected cells were
suspended in 1 ml of the diluted MitoCapture solution, followed
by incubation at 37uC for 20 min. After centrifugation, the cell
pellet was resuspended in 1 ml of the pre-warmed incubation
buffer before measurement by flow cytometry.
Western blot analysis
Twenty-four hours after osajin treatment, cells were washed
twice with cold PBS before incubation in ice-cold lysis buffer
containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 0.5%
Nonidet P-40, 1 mM PMSF, 1 mM NaF, 1 mM sodium
orthovanadate, 1 mM DTT, 10 mM b-glycerophosphate, and
4 mg/ml complete protease inhibitor cocktail over ice for 30 min.
Cell suspensions were then centrifuged for 30 min at 15,0006 g at
4uC, and the supernatant (total cell lysates) was collected and
stored at 270uC. Cytosolic and mitochondrial extracts were
Figure 8. Schematic model for the mechanisms of osajin-induced apoptosis in human NPC cells. Osajin induces apoptosis in human NPC
cells through multiple apoptotic pathways, including death receptor-, mitochondria- and ER stress-dependent pathways.
doi:10.1371/journal.pone.0018308.g008
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prepared using a Mitochondrial/Cytosol Fractionation kit (BioVi-
sion). The protein concentration was determined using Bradford
assay (Bio-Rad, Richmond, CA, USA). Equal amounts of protein
were separated by electrophoresis in 10 to 15% SDS-polyacryl-
amide gels. Protein samples were transferred onto PVDF
membranes (Millipore), and detected by the appropriate primary
and secondary antibodies before visualization using an enhanced
chemiluminescence detection kit (Millipore). The antibodies anti-
Bid, anti-caspase-3, anti-caspase-8, anti-caspase-9 and anti-cyto-
chrome c were from Cell Signaling Technology (Beverly, MA,
USA); anti-Bax, anti-Bcl-2, anti-CHOP, anti-Fas, anti-FasL, anti-
GAPDH and anti-GRP78 antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); anti-caspase-4 was from
MBL (Naka-ku, Nagoya, Japan); and anti-b-actin was from Novus
Biologicals (Littleton, CO, USA). The secondary antibodies were
horseradish peroxidase-conjugated anti-rabbit and anti-mouse
IgG (Santa Cruz Biotechnology).
Immunoprecipitation
The immunoprecipitations were performed according to the
Catch and Release v2.0 Kit (Millipore) following the kit
recommendations. Cell lysates were incubated with anti-Bax or
anti-Bcl-2 antibodies at 4uC overnight on a rotator by using Catch
and Release spin columns. The column was washed 3 times with
16Wash Buffer, spinning at 2,0006 g 15–30 seconds for each
wash. Proteins bound to the beads were eluted by denaturing
elution buffer, separated by SDS-PAGE and immunoblotted with
antibodies against proapoptotic and antiapoptotic proteins to
identify the binding of Bcl-2 family proteins.
RNA isolation and reverse transcriptase-polymerase chain
reaction (RT-PCR)
Total RNA from TW04 cells was extracted with the TRIzol
reagent, according to the manufacturer’s instructions (Invitrogen,
Carlsbad, CA, USA). Two micrograms of RNA were reversely
transcribed in 20 ml reaction volumes containing an oligo (dT)
primer (Invitrogen) and the M-MLV reverse transcriptase
(Promega, Madison, WI, USA). The cDNA for Bax, Bcl-2, CHOP,
GRP78, Fas, FasL and b-actin were amplified by PCR with specific
primers: Bax forward primer 59-TCTGACGGCAACTT-
CAACTG-39, and reverse primer 59-TTGAGGAGTCTCACC-
CAACC-39; Bcl-2 forward primer 59-TCCATGTCTTTGGA-
CAACCA-39, and reverse primer 59-CTCCACCAGTGTTCC-
CATCT-39; CHOP forward primer 59-GCACCTCCCAGAG-
CCCTCACTCTCC-39, and reverse primer 59-GTCTACTC-
CAAGCCTTCCCCCTGCG-39; GRP78 forward primer 59-GC-
TCTCGAATTCCAAAG-39, and reverse primer 59-TTTGT-
CAGGGGTCTTTCACC-39; Fas forward primer 59-GGATGA-
ACCAGACTGCGTG-39, and reverse primer 59-CTGCATGT-
TTTCTGTACTTCC-39; FasL forward primer 59-CTCTG-
GAATGGGAAGACACC-39, and reverse primer 59-ACCAGA-
GAGAGCTCAGATACG-39; b-actin forward primer 59-GAGA-
CCTTCAACACCCCAGCC-39, and reverse primer 59-GGATC-
TTCATGAGGTAGTCAG-39. The PCR products from the same
sample were electrophoresed in a 2% agarose gel and visualized by
ethidium bromide staining on an image system.
Statistical analysis
Data were expressed as mean 6 SE. Comparisons between
untreated control cells and osajin-treated cells were made using
Student’s t-test, unless otherwise stated. The statistically significant
levels were set at *P,0.05.
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